Trv Gp Iv
Latest statistics and disclosures from Trv Gp Iv's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TNGX, PLRX, FULC, and represent 100.00% of Trv Gp Iv's stock portfolio.
- Trv Gp Iv has $246M in assets under management (AUM), dropping by -7.26%.
- Central Index Key (CIK): 0001688325
Tip: Access up to 7 years of quarterly data
Positions held by Trv Gp Iv consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Trv Gp Iv
Trv Gp Iv holds 3 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Tango Therapeutics (TNGX) | 77.9 | $192M | 19M | 9.90 |
|
|
| Pliant Therapeutics (PLRX) | 15.7 | $39M | 2.1M | 18.11 |
|
|
| Fulcrum Therapeutics (FULC) | 6.4 | $16M | 2.3M | 6.75 |
|
Past Filings by Trv Gp Iv
SEC 13F filings are viewable for Trv Gp Iv going back to 2018
- Trv Gp Iv 2023 Q4 filed Feb. 14, 2024
- Trv Gp Iv 2023 Q3 filed Nov. 13, 2023
- Trv Gp Iv 2023 Q2 filed Aug. 10, 2023
- Trv Gp Iv 2023 Q1 filed May 12, 2023
- Trv Gp Iv 2022 Q4 filed Feb. 14, 2023
- Trv Gp Iv 2022 Q3 filed Nov. 3, 2022
- Trv Gp Iv 2022 Q2 filed Aug. 12, 2022
- Trv Gp Iv 2022 Q1 filed May 10, 2022
- Trv Gp Iv 2021 Q4 filed Feb. 14, 2022
- Trv Gp Iv 2021 Q3 filed Nov. 5, 2021
- Trv Gp Iv 2021 Q2 filed Aug. 11, 2021
- Trv Gp Iv 2021 Q1 filed May 12, 2021
- Trv Gp Iv 2020 Q4 filed Feb. 16, 2021
- Trv Gp Iv 2020 Q3 filed Nov. 6, 2020
- Trv Gp Iv 2020 Q2 filed Aug. 10, 2020
- Trv Gp Iv 2020 Q1 filed May 11, 2020